Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.


Autoria(s): Straumann A.; Conus S.; Degen L.; Frei C.; Bussmann C.; Beglinger C.; Schoepfer A.; Simon H.U.
Data(s)

2011

Identificador

http://serval.unil.ch/?id=serval:BIB_B767F6954525

isbn:1542-3565

pmid:21277394

doi:10.1016/j.cgh.2011.01.017

isiid:000290657200015

Idioma(s)

en

Fonte

Clinical Gastroenterology and Hepatology, vol. 9, no. 5, pp. 400-9.e1

Palavras-Chave #Administration, Oral; Adult; Anti-Inflammatory Agents/administration & dosage; Budesonide/administration & dosage; Chronic Disease; Double-Blind Method; Eosinophilic Esophagitis/drug therapy; Eosinophilic Esophagitis/pathology; Esophagus/pathology; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Middle Aged; Placebos/administration & dosage; Recurrence/prevention & control; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article